HOLX Valuation

Hologic Inc

Add to Watchlist

Advanced Chart

57.850

+0.690(+1.210%)

Overview
Forecast
Valuation

HOLX Relative Valuation

HOLX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, HOLX is overvalued; if below, it's undervalued.

Historical Valuation

Hologic Inc (HOLX) is now in the Undervalued zone, suggesting that its current forward PE ratio of 13.15 is considered Undervalued compared with the five-year average of 17.50. The fair price of Hologic Inc (HOLX) is between 66.89 to 94.06 according to relative valuation methord. Compared to the current price of 57.85 USD , Hologic Inc is Undervalued By 13.51%.

Relative Value

Fair Zone

66.89-94.06

Current Price：57.85

13.51%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

2.70

P/B

Median3y

3.60

Median5y

4.34

8.50

FCF Yield

Median3y

7.49

Median5y

7.69

Competitors Valuation Multiple

The average P/S ratio for HOLX's competitors is 3.40, providing a benchmark for relative valuation. Hologic Inc Corp (HOLX) exhibits a P/S ratio of 3.23, which is -5.06% above the industry average. Given its robust revenue growth of 0.86%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap